Sanofi Ventures
Portfolio in Switzerland · Spain: 3 funded startups tracked by Uback, 3 of them in a ranking.
Portfolio on Uback3startups, 2 countries
In a ranking3ranked by AI-estimated valuation
On the Radar0eligible, not ranked
Latest deal trackedMay 2026Windward Bio
Portfolio on Uback
Sorted by Uback rank, then Radar by last round| Company | Uback | Sector | Round backed | Valuation (AI) |
|---|---|---|---|---|
| Windward Bio | #9 Switzerland | Biotech › respiratory antibodies | Crossover · USD 160M · May 2026 | Hundreds of M$ |
| SpliceBio | #11 Spain | Biotech › gene therapy (ophthalmology) | Series B · USD 135M (EUR 118M) · Jun 2025 | Hundreds of M$ |
| Granite Bio | #20 Switzerland | Biotech › immunology antibodies | Series A + B · USD 100M · Apr 2025 | Hundreds of M$ |
Only startups that meet Uback’s eligibility rules are shown. Amounts are round sizes, not the fund’s share. Rounds as reported by public sources.
By sector
Deals tracked per year
22025
12026
Co-investors
EQT Life Sciences · Roche Venture Fund · OrbiMed · RA Capital · Janus Henderson · Harbour BioMed · Versant Ventures · Novartis Venture Fund · Forbion
Investors that joined the same rounds, as reported by public sources.
Last updated: Oct 2026Report a missing dealReport an error
Uback is a content publisher. It provides no investment advice, receives no mandate and takes part in no transaction.